<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03112473</url>
  </required_header>
  <id_info>
    <org_study_id>HMRF_SNg</org_study_id>
    <nct_id>NCT03112473</nct_id>
  </id_info>
  <brief_title>Effect of Bilateral TENS With TOT on Upper Limb Function in Patients With Chronic Stroke</brief_title>
  <official_title>A Randomized, Controlled Clinical Trial of Upper Limb Training With Bilateral Cutaneous Electrical Stimulation to Improve Upper Limb Functions in Patients With Chronic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hong Kong Polytechnic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      On the basis that the combined use of Uni-TENS and TRT is an effective intervention in upper&#xD;
      limb recovery, and the advantage of Bi-TENS eliciting extra neural pathway in the intact&#xD;
      hemisphere to facilitate the motor recovery, There is a research gap in whether the Bi-TENS&#xD;
      over both the paretic and non-paretic limbs could probably augment the treatment effects of&#xD;
      TOT in upper limb motor control in people with stroke.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine whether Bi-TENS+TOT was superior to Uni-TENS+TOT,&#xD;
      Placebo-TENS+TOT alone and no active treatment in improving the upper limb motor control and&#xD;
      upper limb function and community integration in people with chronic stroke.&#xD;
&#xD;
      The null hypothesis will be that Bi-TENS+TOT is not significantly different from&#xD;
      Uni-TENS+TOT,Placebo-TENS+TOT alone and no active treatment in improving the upper limb motor&#xD;
      control and upper limb function and community integration in people with chronic stroke.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 24, 2016</start_date>
  <completion_date type="Actual">October 24, 2020</completion_date>
  <primary_completion_date type="Actual">October 24, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The participant and outcome assessor were blinded to the group allocation</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl Meyer Assessment on Upper Extremity (FMA-UE)</measure>
    <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
    <description>FMA-UE was used for evaluating the upper limb motor control from proximal to distal part of the limb, and voluntary movement from synergistic to isolated in people with stroke. The FMA-UE has shoulder-arm, wrist, hand and coordination and speed subsections. The score of shoulder-arm, wrist, hand and coordination and speed sub-scale are combined to compute the total score. The maximum total score is 66, with 33 items and ordinal scoring from 0 to 2. A higher score of FMA-UE indicated a higher level of upper limb motor control.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Jacket Test (JT)</measure>
    <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
    <description>Jacket Test is one of the items in the Physical Performance Test. The subject is required to don a jacket or a cardigan sweater such that it is straight on his or her shoulders, and then remove it completely. The time for completing the task is recorded.(Rueben DB et al, 1990) This Jacket Test (JT) can be used to evaluate the functional mobility of the upper limbs as the test involves abduction of the shoulder joint, flexion and extension of the elbow joint and gripping with the hands.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Voluntary Contraction (MVC)-Peak Torque</measure>
    <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
    <description>The force data would be recorded by the self-made load cell. And the mean value peak torque of the joint would be calculated by the force and the length from the wrist joint to the head of 3rd metacarpal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Action Research Arm Test (ARAT)</measure>
    <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
    <description>ARAT will be used to assess the 4 aspects of upper limb function(grasp, grip, pinch and gross arm movement). This scale is consistent of 19 items. The quality of performance on each item is rated from 0-3, so the score of ARAT is ranged from 0-57. The score of rasp, grip, pinch and gross arm movement sub-scale are combined to compute the total score. The scores for the 15 tasks will be summed and then averaged to yield the mean functional ability score. A higher ARAT score indicated a higher upper limb motor function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Range of Motion (ROM) of Upper Limb Joints</measure>
    <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
    <description>With 0° shoulder flexion and 90° elbow flexion, the forearm and wrist will be placed in a neutral position in the relaxed phase. When the task begins, the subjects will be asked to perform the full range of motion for wrist flexion/extension. With 90° shoulder flexion and 0° elbow flexion, the forearm will be placed in a neutral position in the relaxed phase. When the task begins, the subjects will be asked to perform the full range of motion for elbow flexion/extension.&#xD;
All the subjects will be requested to perform their joint ROM to the best of their abilities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Activity Log (MAL)</measure>
    <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
    <description>The MAL questionnaire will be used to assess how frequently and how well a person uses the paretic upper limb in 30 activities of daily life in a semi-structured interview. Based on a six-point ordinal scale, subjects will be required to rate (1) the amount of use (AOU), and (2) the quality of movement (QOM) when performing these 30 tasks in real life situations. Each task was rated from 0 to 5. The score of the 30 activities of daily life were combined to compute the total score of MAL-AOU and MAL-QOM, respectively. Hence, the total score of AOU and QOM component were rated from 0 to 150. The higher MAL-AOU score indicated a higher frequency use of the paretic upper limb, and the higher MAL-QOM score indicated a higher movement quality of the paretic upper limb.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chinese Version of Community Integration Measure (CIM)</measure>
    <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
    <description>The Chinese version of CIM was used to assess the level of community integration of the subjects. The CIM-C has been shown to have good internal consistency and good test-retest reliability for people with stroke . CIM has 10 items, each item rate from 1-5, giving a minimum score of 10 to a maximum of 50. A higher score indicated a higher level of community integration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Voluntary Contraction (MVC)-Cocontraction Ratio</measure>
    <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
    <description>EMG signal of Radial Carpi Extensor and Ulnar Carpi Flexor for both affected and unaffected side would be recorded by the surface EMG electrodes when asked the subjects to perform the MVC of wrist extension and flexion for 5s in each trial. Each movement would perform 3 times. The data of the 3 trials will be averaged. The co-contraction ratio would be calculated by the iEMG area of antagonist to total (agonist+antagonist), which would be captured for 0.5s from the window began at 0.25s before and ended at 0.25s after the peak value of MVC.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Bilateral TENS (Bi-TENS) group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unilateral TENS (uni-TENS) group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side and sham electrical stimulation on the non-paretic side</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No Active intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Task-orientated training</intervention_name>
    <description>Task-Oriented Training (TOT) is a goal-directed exercise therapy, which help the people derive optimal control strategies for solving specific motor problems in real environment. In this study, TOT included stretching exercises, mobilizing exercise, strengthening exercises, seated reaching tasks, dexterity training and bimanual practice.</description>
    <arm_group_label>Bilateral TENS (Bi-TENS) group</arm_group_label>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_label>Unilateral TENS (uni-TENS) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous electrical nerve stimulation (TENS)</intervention_name>
    <description>The stimulator was 120z Dual-Channel TENS Unit (ITO PHYSITHERAPY&amp;REHABILITION CO., LTD, Tokyo, Japan). The parameter (100 Hz, 0.2 ms square pulses, intensity barely below the motor threshold) of TENS followed our previous study</description>
    <arm_group_label>Bilateral TENS (Bi-TENS) group</arm_group_label>
    <arm_group_label>Unilateral TENS (uni-TENS) group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham electrical nerve stimulation</intervention_name>
    <description>A identical-looking TENS devices that electrical circuit has been disconnected.</description>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_label>Unilateral TENS (uni-TENS) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects will be recruited from local self-help groups through poster advertising.&#xD;
&#xD;
          -  Subjects will be included if they are between 50 and 80 years of age&#xD;
&#xD;
          -  Have been diagnosed with ischaemic brain injury or intracerebral hemorrhage by MRI or&#xD;
             computed tomography within the previous 1 to 10 years&#xD;
&#xD;
          -  have volitional control of the non-paretic arm and at least minimal antigravity&#xD;
             movement in the shoulder of the paretic arm,&#xD;
&#xD;
          -  have at least 5º in wrist extension in the antigravity position,&#xD;
&#xD;
          -  score &gt; 6 out of 10 in the Abbreviated Mental Test, and&#xD;
&#xD;
          -  are able to follow instructions and give informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • have any additional medical, cardiovascular or orthopedic condition&#xD;
&#xD;
               -  use a cardiac pacemaker&#xD;
&#xD;
               -  have receptive dysphasia&#xD;
&#xD;
               -  have a significant upper limb peripheral neuropathy&#xD;
&#xD;
               -  are involved in drug studies or other clinical trials, or&#xD;
&#xD;
               -  have severe shoulder, elbow, wrist or finger contractures that would preclude a&#xD;
                  passive range of motions of the arm, and&#xD;
&#xD;
               -  have a skin allergy that would prevent electrical stimulation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Hong Kong Polytechnic University</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <results_first_submitted>November 24, 2020</results_first_submitted>
  <results_first_submitted_qc>March 25, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 20, 2021</results_first_posted>
  <last_update_submitted>April 19, 2021</last_update_submitted>
  <last_update_submitted_qc>April 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hong Kong Polytechnic University</investigator_affiliation>
    <investigator_full_name>Shamay Ng</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>upper limb</keyword>
  <keyword>transcutaneous electrical nerve stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 1, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT03112473/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bilateral TENS (Bi-TENS) Group</title>
          <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation&#xD;
Task-orientated training: Bi/Uni/Placebo TENS and Task-orientated training on upper limb&#xD;
Transcutaneous electrical nerve stimulation (TENS)</description>
        </group>
        <group group_id="P2">
          <title>Unilateral TENS (Uni-TENS) Group</title>
          <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side&#xD;
Task-orientated training: Bi/Uni/Placebo TENS and Task-orientated training on upper limb&#xD;
Transcutaneous electrical nerve stimulation (TENS)</description>
        </group>
        <group group_id="P3">
          <title>Placebo Group</title>
          <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation&#xD;
Task-orientated training: Bi/Uni/Placebo TENS and Task-orientated training on upper limb&#xD;
Sham electrical nerve stimulation</description>
        </group>
        <group group_id="P4">
          <title>Control Group</title>
          <description>No Active intervention</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="30"/>
                <participants group_id="P4" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="30"/>
                <participants group_id="P4" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Bilateral TENS (Bi-TENS) Group</title>
          <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 7 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation</description>
        </group>
        <group group_id="B2">
          <title>Unilateral TENS (Uni-TENS) Group</title>
          <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 7 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side</description>
        </group>
        <group group_id="B3">
          <title>Placebo Group</title>
          <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 7 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation</description>
        </group>
        <group group_id="B4">
          <title>Control Group</title>
          <description>No Active intervention</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="30"/>
            <count group_id="B4" value="30"/>
            <count group_id="B5" value="120"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="22"/>
                    <measurement group_id="B5" value="89"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.37" spread="7.13"/>
                    <measurement group_id="B2" value="62.30" spread="7.30"/>
                    <measurement group_id="B3" value="61.70" spread="6.70"/>
                    <measurement group_id="B4" value="61.70" spread="5.91"/>
                    <measurement group_id="B5" value="61.52" spread="6.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="30"/>
                    <measurement group_id="B5" value="120"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hong Kong</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="30"/>
                    <measurement group_id="B5" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fugl-Meyer Assessment of Upper Extremity</title>
          <description>FMA-UE was used for evaluating the upper limb motor control from proximal to distal part of the limb, and voluntary movement from synergistic to isolated in people with stroke. The FMA-UE has shoulder-arm, wrist, hand and coordination and speed subsections. The score of shoulder-arm, wrist, hand and coordination and speed sub-scale are combined to compute the total score. The maximum total score is 66, with 33 items and ordinal scoring from 0 to 2. A higher score of FMA-UE indicated a higher level of upper limb motor control.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.03" spread="12.02"/>
                    <measurement group_id="B2" value="41.83" spread="17.12"/>
                    <measurement group_id="B3" value="38.77" spread="15.78"/>
                    <measurement group_id="B4" value="43.93" spread="18.74"/>
                    <measurement group_id="B5" value="40.39" spread="16.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Fugl Meyer Assessment on Upper Extremity (FMA-UE)</title>
        <description>FMA-UE was used for evaluating the upper limb motor control from proximal to distal part of the limb, and voluntary movement from synergistic to isolated in people with stroke. The FMA-UE has shoulder-arm, wrist, hand and coordination and speed subsections. The score of shoulder-arm, wrist, hand and coordination and speed sub-scale are combined to compute the total score. The maximum total score is 66, with 33 items and ordinal scoring from 0 to 2. A higher score of FMA-UE indicated a higher level of upper limb motor control.</description>
        <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bilateral TENS (Bi-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation</description>
          </group>
          <group group_id="O2">
            <title>Unilateral TENS (Uni-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side</description>
          </group>
          <group group_id="O3">
            <title>Placebo Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation</description>
          </group>
          <group group_id="O4">
            <title>Control Group</title>
            <description>No Active intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Fugl Meyer Assessment on Upper Extremity (FMA-UE)</title>
          <description>FMA-UE was used for evaluating the upper limb motor control from proximal to distal part of the limb, and voluntary movement from synergistic to isolated in people with stroke. The FMA-UE has shoulder-arm, wrist, hand and coordination and speed subsections. The score of shoulder-arm, wrist, hand and coordination and speed sub-scale are combined to compute the total score. The maximum total score is 66, with 33 items and ordinal scoring from 0 to 2. A higher score of FMA-UE indicated a higher level of upper limb motor control.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.03" spread="12.02"/>
                    <measurement group_id="O2" value="41.83" spread="17.12"/>
                    <measurement group_id="O3" value="38.77" spread="15.78"/>
                    <measurement group_id="O4" value="43.93" spread="18.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mid-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.27" spread="13.38"/>
                    <measurement group_id="O2" value="43.60" spread="17.21"/>
                    <measurement group_id="O3" value="40.13" spread="15.41"/>
                    <measurement group_id="O4" value="44.87" spread="17.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.43" spread="13.73"/>
                    <measurement group_id="O2" value="44.23" spread="16.12"/>
                    <measurement group_id="O3" value="40.23" spread="14.97"/>
                    <measurement group_id="O4" value="44.20" spread="18.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-month followed up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.60" spread="13.36"/>
                    <measurement group_id="O2" value="42.70" spread="17.35"/>
                    <measurement group_id="O3" value="40.90" spread="14.43"/>
                    <measurement group_id="O4" value="45.03" spread="17.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month followed up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.17" spread="13.61"/>
                    <measurement group_id="O2" value="43.17" spread="18.65"/>
                    <measurement group_id="O3" value="40.60" spread="14.67"/>
                    <measurement group_id="O4" value="45.23" spread="17.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Jacket Test (JT)</title>
        <description>Jacket Test is one of the items in the Physical Performance Test. The subject is required to don a jacket or a cardigan sweater such that it is straight on his or her shoulders, and then remove it completely. The time for completing the task is recorded.(Rueben DB et al, 1990) This Jacket Test (JT) can be used to evaluate the functional mobility of the upper limbs as the test involves abduction of the shoulder joint, flexion and extension of the elbow joint and gripping with the hands.</description>
        <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
        <population>Nine subjects (Uni-TENS+TOT: 3; Placebo-TENS+TOT: 1; Control: 5) could not complete JT due to difficulty in maintaining the standing position without physical aids.</population>
        <group_list>
          <group group_id="O1">
            <title>Bilateral TENS (Bi-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation</description>
          </group>
          <group group_id="O2">
            <title>Unilateral TENS (Uni-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side</description>
          </group>
          <group group_id="O3">
            <title>Placebo Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation</description>
          </group>
          <group group_id="O4">
            <title>Control Group</title>
            <description>No Active intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Jacket Test (JT)</title>
          <description>Jacket Test is one of the items in the Physical Performance Test. The subject is required to don a jacket or a cardigan sweater such that it is straight on his or her shoulders, and then remove it completely. The time for completing the task is recorded.(Rueben DB et al, 1990) This Jacket Test (JT) can be used to evaluate the functional mobility of the upper limbs as the test involves abduction of the shoulder joint, flexion and extension of the elbow joint and gripping with the hands.</description>
          <population>Nine subjects (Uni-TENS+TOT: 3; Placebo-TENS+TOT: 1; Control: 5) could not complete JT due to difficulty in maintaining the standing position without physical aids.</population>
          <units>second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.51" spread="12.44"/>
                    <measurement group_id="O2" value="36.98" spread="22.02"/>
                    <measurement group_id="O3" value="36.87" spread="17.53"/>
                    <measurement group_id="O4" value="33.36" spread="21.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mid-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.02" spread="13.66"/>
                    <measurement group_id="O2" value="35.78" spread="20.92"/>
                    <measurement group_id="O3" value="36.86" spread="15.53"/>
                    <measurement group_id="O4" value="32.58" spread="23.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.55" spread="11.70"/>
                    <measurement group_id="O2" value="30.67" spread="15.66"/>
                    <measurement group_id="O3" value="34.71" spread="16.08"/>
                    <measurement group_id="O4" value="34.08" spread="23.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.35" spread="12.46"/>
                    <measurement group_id="O2" value="32.83" spread="20.32"/>
                    <measurement group_id="O3" value="34.24" spread="18.25"/>
                    <measurement group_id="O4" value="31.47" spread="21.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.00" spread="12.51"/>
                    <measurement group_id="O2" value="32.54" spread="18.11"/>
                    <measurement group_id="O3" value="34.24" spread="17.19"/>
                    <measurement group_id="O4" value="31.77" spread="22.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximal Voluntary Contraction (MVC)-Peak Torque</title>
        <description>The force data would be recorded by the self-made load cell. And the mean value peak torque of the joint would be calculated by the force and the length from the wrist joint to the head of 3rd metacarpal.</description>
        <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bilateral TENS (Bi-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation</description>
          </group>
          <group group_id="O2">
            <title>Unilateral TENS (Uni-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side</description>
          </group>
          <group group_id="O3">
            <title>Placebo Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation</description>
          </group>
          <group group_id="O4">
            <title>Control Group</title>
            <description>No Active intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Maximal Voluntary Contraction (MVC)-Peak Torque</title>
          <description>The force data would be recorded by the self-made load cell. And the mean value peak torque of the joint would be calculated by the force and the length from the wrist joint to the head of 3rd metacarpal.</description>
          <units>N*m</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Peak Torque-wrist flexion-Pre-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.69" spread="1.79"/>
                    <measurement group_id="O2" value="4.51" spread="2.63"/>
                    <measurement group_id="O3" value="4.86" spread="2.82"/>
                    <measurement group_id="O4" value="5.13" spread="2.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peak Torque-wrist flexion-Mid-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.40" spread="1.90"/>
                    <measurement group_id="O2" value="4.77" spread="2.74"/>
                    <measurement group_id="O3" value="4.71" spread="2.74"/>
                    <measurement group_id="O4" value="5.35" spread="2.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peak Torque-wrist flexion-Post-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.10" spread="2.17"/>
                    <measurement group_id="O2" value="4.74" spread="2.43"/>
                    <measurement group_id="O3" value="4.94" spread="2.58"/>
                    <measurement group_id="O4" value="5.39" spread="2.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peak Torque-wrist flexion- 1-month followed up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.86" spread="2.30"/>
                    <measurement group_id="O2" value="4.85" spread="2.60"/>
                    <measurement group_id="O3" value="5.17" spread="2.84"/>
                    <measurement group_id="O4" value="5.57" spread="2.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peak Torque-wrist flexion- 3-month followed up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.08" spread="2.12"/>
                    <measurement group_id="O2" value="4.89" spread="2.50"/>
                    <measurement group_id="O3" value="5.28" spread="2.62"/>
                    <measurement group_id="O4" value="5.70" spread="2.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peak Torque-wrist extension-Pre-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.38" spread="1.95"/>
                    <measurement group_id="O2" value="3.12" spread="2.36"/>
                    <measurement group_id="O3" value="3.40" spread="2.17"/>
                    <measurement group_id="O4" value="3.64" spread="2.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peak Torque-wrist extension-Mid-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.62" spread="1.70"/>
                    <measurement group_id="O2" value="3.10" spread="2.46"/>
                    <measurement group_id="O3" value="3.41" spread="2.48"/>
                    <measurement group_id="O4" value="3.55" spread="2.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peak Torque-wrist extension-Post-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.77" spread="1.70"/>
                    <measurement group_id="O2" value="3.58" spread="2.74"/>
                    <measurement group_id="O3" value="3.81" spread="2.62"/>
                    <measurement group_id="O4" value="3.71" spread="2.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peak Torque-wrist extension- 1-month followed up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.87" spread="1.89"/>
                    <measurement group_id="O2" value="3.67" spread="2.82"/>
                    <measurement group_id="O3" value="3.61" spread="2.35"/>
                    <measurement group_id="O4" value="3.81" spread="2.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Peak Torque-wrist extension- 3-month followed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.91" spread="1.98"/>
                    <measurement group_id="O2" value="3.86" spread="2.76"/>
                    <measurement group_id="O3" value="3.66" spread="2.86"/>
                    <measurement group_id="O4" value="3.98" spread="2.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Action Research Arm Test (ARAT)</title>
        <description>ARAT will be used to assess the 4 aspects of upper limb function(grasp, grip, pinch and gross arm movement). This scale is consistent of 19 items. The quality of performance on each item is rated from 0-3, so the score of ARAT is ranged from 0-57. The score of rasp, grip, pinch and gross arm movement sub-scale are combined to compute the total score. The scores for the 15 tasks will be summed and then averaged to yield the mean functional ability score. A higher ARAT score indicated a higher upper limb motor function.</description>
        <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bilateral TENS (Bi-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation</description>
          </group>
          <group group_id="O2">
            <title>Unilateral TENS (Uni-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side</description>
          </group>
          <group group_id="O3">
            <title>Placebo Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation</description>
          </group>
          <group group_id="O4">
            <title>Control Group</title>
            <description>No Active intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Action Research Arm Test (ARAT)</title>
          <description>ARAT will be used to assess the 4 aspects of upper limb function(grasp, grip, pinch and gross arm movement). This scale is consistent of 19 items. The quality of performance on each item is rated from 0-3, so the score of ARAT is ranged from 0-57. The score of rasp, grip, pinch and gross arm movement sub-scale are combined to compute the total score. The scores for the 15 tasks will be summed and then averaged to yield the mean functional ability score. A higher ARAT score indicated a higher upper limb motor function.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.70" spread="20.09"/>
                    <measurement group_id="O2" value="31.73" spread="20.09"/>
                    <measurement group_id="O3" value="28.30" spread="21.69"/>
                    <measurement group_id="O4" value="34.97" spread="21.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mid-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.27" spread="20.86"/>
                    <measurement group_id="O2" value="33.93" spread="20.27"/>
                    <measurement group_id="O3" value="29.40" spread="20.85"/>
                    <measurement group_id="O4" value="35.30" spread="21.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.40" spread="19.77"/>
                    <measurement group_id="O2" value="33.13" spread="20.80"/>
                    <measurement group_id="O3" value="30.30" spread="21.65"/>
                    <measurement group_id="O4" value="36.07" spread="22.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.33" spread="19.24"/>
                    <measurement group_id="O2" value="34.90" spread="19.74"/>
                    <measurement group_id="O3" value="31.03" spread="21.83"/>
                    <measurement group_id="O4" value="36.77" spread="21.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.20" spread="20.12"/>
                    <measurement group_id="O2" value="33.33" spread="21.17"/>
                    <measurement group_id="O3" value="30.43" spread="21.97"/>
                    <measurement group_id="O4" value="36.27" spread="22.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Range of Motion (ROM) of Upper Limb Joints</title>
        <description>With 0° shoulder flexion and 90° elbow flexion, the forearm and wrist will be placed in a neutral position in the relaxed phase. When the task begins, the subjects will be asked to perform the full range of motion for wrist flexion/extension. With 90° shoulder flexion and 0° elbow flexion, the forearm will be placed in a neutral position in the relaxed phase. When the task begins, the subjects will be asked to perform the full range of motion for elbow flexion/extension.&#xD;
All the subjects will be requested to perform their joint ROM to the best of their abilities.</description>
        <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bilateral TENS (Bi-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation</description>
          </group>
          <group group_id="O2">
            <title>Unilateral TENS (Uni-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side</description>
          </group>
          <group group_id="O3">
            <title>Placebo Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation</description>
          </group>
          <group group_id="O4">
            <title>Control Group</title>
            <description>No Active intervention</description>
          </group>
        </group_list>
        <measure>
          <title>The Range of Motion (ROM) of Upper Limb Joints</title>
          <description>With 0° shoulder flexion and 90° elbow flexion, the forearm and wrist will be placed in a neutral position in the relaxed phase. When the task begins, the subjects will be asked to perform the full range of motion for wrist flexion/extension. With 90° shoulder flexion and 0° elbow flexion, the forearm will be placed in a neutral position in the relaxed phase. When the task begins, the subjects will be asked to perform the full range of motion for elbow flexion/extension.&#xD;
All the subjects will be requested to perform their joint ROM to the best of their abilities.</description>
          <units>degree</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Elbow-Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.67" spread="28.89"/>
                    <measurement group_id="O2" value="85.73" spread="27.30"/>
                    <measurement group_id="O3" value="82.88" spread="24.01"/>
                    <measurement group_id="O4" value="90.22" spread="33.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elbow-Mid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.70" spread="22.96"/>
                    <measurement group_id="O2" value="84.33" spread="28.58"/>
                    <measurement group_id="O3" value="86.75" spread="22.64"/>
                    <measurement group_id="O4" value="79.28" spread="29.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elbow-Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.70" spread="23.78"/>
                    <measurement group_id="O2" value="88.47" spread="26.07"/>
                    <measurement group_id="O3" value="83.60" spread="18.82"/>
                    <measurement group_id="O4" value="86.75" spread="23.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elbow-1-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.13" spread="30.91"/>
                    <measurement group_id="O2" value="84.05" spread="29.51"/>
                    <measurement group_id="O3" value="81.85" spread="23.81"/>
                    <measurement group_id="O4" value="89.67" spread="26.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elbow-3-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.13" spread="33.79"/>
                    <measurement group_id="O2" value="89.90" spread="30.74"/>
                    <measurement group_id="O3" value="81.95" spread="20.10"/>
                    <measurement group_id="O4" value="87.02" spread="27.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wrist-Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.42" spread="40.84"/>
                    <measurement group_id="O2" value="69.97" spread="49.52"/>
                    <measurement group_id="O3" value="72.70" spread="44.04"/>
                    <measurement group_id="O4" value="87.41" spread="48.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wrist-Mid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.43" spread="36.45"/>
                    <measurement group_id="O2" value="74.77" spread="47.35"/>
                    <measurement group_id="O3" value="62.23" spread="50.02"/>
                    <measurement group_id="O4" value="87.72" spread="40.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wrist-Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.83" spread="35.51"/>
                    <measurement group_id="O2" value="75.42" spread="47.96"/>
                    <measurement group_id="O3" value="69.77" spread="42.35"/>
                    <measurement group_id="O4" value="90.07" spread="42.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wrist-1-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.92" spread="37.84"/>
                    <measurement group_id="O2" value="78.30" spread="48.23"/>
                    <measurement group_id="O3" value="66.05" spread="38.46"/>
                    <measurement group_id="O4" value="87.97" spread="46.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wrist-3-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.67" spread="39.57"/>
                    <measurement group_id="O2" value="78.32" spread="54.34"/>
                    <measurement group_id="O3" value="71.18" spread="44.39"/>
                    <measurement group_id="O4" value="90.78" spread="45.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Motor Activity Log (MAL)</title>
        <description>The MAL questionnaire will be used to assess how frequently and how well a person uses the paretic upper limb in 30 activities of daily life in a semi-structured interview. Based on a six-point ordinal scale, subjects will be required to rate (1) the amount of use (AOU), and (2) the quality of movement (QOM) when performing these 30 tasks in real life situations. Each task was rated from 0 to 5. The score of the 30 activities of daily life were combined to compute the total score of MAL-AOU and MAL-QOM, respectively. Hence, the total score of AOU and QOM component were rated from 0 to 150. The higher MAL-AOU score indicated a higher frequency use of the paretic upper limb, and the higher MAL-QOM score indicated a higher movement quality of the paretic upper limb.</description>
        <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bilateral TENS (Bi-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation</description>
          </group>
          <group group_id="O2">
            <title>Unilateral TENS (Uni-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side</description>
          </group>
          <group group_id="O3">
            <title>Placebo Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation</description>
          </group>
          <group group_id="O4">
            <title>Control Group</title>
            <description>No Active intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Motor Activity Log (MAL)</title>
          <description>The MAL questionnaire will be used to assess how frequently and how well a person uses the paretic upper limb in 30 activities of daily life in a semi-structured interview. Based on a six-point ordinal scale, subjects will be required to rate (1) the amount of use (AOU), and (2) the quality of movement (QOM) when performing these 30 tasks in real life situations. Each task was rated from 0 to 5. The score of the 30 activities of daily life were combined to compute the total score of MAL-AOU and MAL-QOM, respectively. Hence, the total score of AOU and QOM component were rated from 0 to 150. The higher MAL-AOU score indicated a higher frequency use of the paretic upper limb, and the higher MAL-QOM score indicated a higher movement quality of the paretic upper limb.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>AOU-Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.03" spread="30.35"/>
                    <measurement group_id="O2" value="49.72" spread="47.73"/>
                    <measurement group_id="O3" value="39.20" spread="40.54"/>
                    <measurement group_id="O4" value="45.28" spread="34.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AOU-Mid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.57" spread="35.59"/>
                    <measurement group_id="O2" value="44.93" spread="47.92"/>
                    <measurement group_id="O3" value="53.27" spread="50.99"/>
                    <measurement group_id="O4" value="47.73" spread="43.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AOU-Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.53" spread="38.86"/>
                    <measurement group_id="O2" value="48.87" spread="49.56"/>
                    <measurement group_id="O3" value="54.70" spread="50.15"/>
                    <measurement group_id="O4" value="45.10" spread="44.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AOU-1-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.95" spread="31.91"/>
                    <measurement group_id="O2" value="48.68" spread="49.49"/>
                    <measurement group_id="O3" value="48.58" spread="50.04"/>
                    <measurement group_id="O4" value="49.25" spread="50.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>AOU-3-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.80" spread="34.42"/>
                    <measurement group_id="O2" value="58.03" spread="54.14"/>
                    <measurement group_id="O3" value="50.53" spread="48.84"/>
                    <measurement group_id="O4" value="46.42" spread="46.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QOM-Pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.10" spread="36.15"/>
                    <measurement group_id="O2" value="56.92" spread="49.89"/>
                    <measurement group_id="O3" value="52.42" spread="45.09"/>
                    <measurement group_id="O4" value="58.00" spread="43.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QOM-Mid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.83" spread="37.57"/>
                    <measurement group_id="O2" value="53.20" spread="47.32"/>
                    <measurement group_id="O3" value="61.10" spread="53.46"/>
                    <measurement group_id="O4" value="51.53" spread="46.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QOM-Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.93" spread="35.97"/>
                    <measurement group_id="O2" value="61.38" spread="53.73"/>
                    <measurement group_id="O3" value="51.53" spread="46.76"/>
                    <measurement group_id="O4" value="52.77" spread="44.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QOM-1-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.05" spread="35.85"/>
                    <measurement group_id="O2" value="54.00" spread="51.32"/>
                    <measurement group_id="O3" value="54.88" spread="53.83"/>
                    <measurement group_id="O4" value="57.13" spread="53.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>QOM-3-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.28" spread="39.07"/>
                    <measurement group_id="O2" value="59.08" spread="54.20"/>
                    <measurement group_id="O3" value="54.23" spread="50.13"/>
                    <measurement group_id="O4" value="57.18" spread="50.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chinese Version of Community Integration Measure (CIM)</title>
        <description>The Chinese version of CIM was used to assess the level of community integration of the subjects. The CIM-C has been shown to have good internal consistency and good test-retest reliability for people with stroke . CIM has 10 items, each item rate from 1-5, giving a minimum score of 10 to a maximum of 50. A higher score indicated a higher level of community integration.</description>
        <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bilateral TENS (Bi-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation</description>
          </group>
          <group group_id="O2">
            <title>Unilateral TENS (Uni-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side</description>
          </group>
          <group group_id="O3">
            <title>Placebo Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation</description>
          </group>
          <group group_id="O4">
            <title>Control Group</title>
            <description>No Active intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Chinese Version of Community Integration Measure (CIM)</title>
          <description>The Chinese version of CIM was used to assess the level of community integration of the subjects. The CIM-C has been shown to have good internal consistency and good test-retest reliability for people with stroke . CIM has 10 items, each item rate from 1-5, giving a minimum score of 10 to a maximum of 50. A higher score indicated a higher level of community integration.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.47" spread="7.51"/>
                    <measurement group_id="O2" value="41.23" spread="6.89"/>
                    <measurement group_id="O3" value="41.87" spread="8.02"/>
                    <measurement group_id="O4" value="39.67" spread="9.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mid-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.23" spread="6.60"/>
                    <measurement group_id="O2" value="39.90" spread="11.79"/>
                    <measurement group_id="O3" value="42.20" spread="7.40"/>
                    <measurement group_id="O4" value="38.37" spread="9.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.17" spread="7.04"/>
                    <measurement group_id="O2" value="41.67" spread="9.66"/>
                    <measurement group_id="O3" value="42.17" spread="8.33"/>
                    <measurement group_id="O4" value="39.80" spread="9.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.63" spread="6.96"/>
                    <measurement group_id="O2" value="42.70" spread="12.92"/>
                    <measurement group_id="O3" value="43.17" spread="7.00"/>
                    <measurement group_id="O4" value="39.33" spread="9.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month followed-up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.10" spread="7.16"/>
                    <measurement group_id="O2" value="40.23" spread="10.45"/>
                    <measurement group_id="O3" value="41.03" spread="7.93"/>
                    <measurement group_id="O4" value="41.10" spread="8.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximal Voluntary Contraction (MVC)-Cocontraction Ratio</title>
        <description>EMG signal of Radial Carpi Extensor and Ulnar Carpi Flexor for both affected and unaffected side would be recorded by the surface EMG electrodes when asked the subjects to perform the MVC of wrist extension and flexion for 5s in each trial. Each movement would perform 3 times. The data of the 3 trials will be averaged. The co-contraction ratio would be calculated by the iEMG area of antagonist to total (agonist+antagonist), which would be captured for 0.5s from the window began at 0.25s before and ended at 0.25s after the peak value of MVC.</description>
        <time_frame>Pre-intervention, Mid-intervention (4 weeks), Post-intervention (8 weeks), Follow-up 1 month (12 weeks), Follow-up 3 months (20 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bilateral TENS (Bi-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation&#xD;
Task-orientated training: Task-Oriented Training (TOT) is a goal-directed exercise therapy, which help the people derive optimal control strategies for solving specific motor problems in real environment. In this study, TOT included stretching exercises, mobilizing exercise, strengthening exercises, seated reaching tasks, dexterity training and bimanual practice.&#xD;
Transcutaneous electrical nerve stimulation (TENS): The stimulator was 120z Dual-Channel TENS Unit (ITO PHYSITHERAPY&amp;REHABILITION CO., LTD, Tokyo, Japan). The parameter (100 Hz, 0.2 ms square pulses, intensity barely below the motor threshold) of TENS followed our previous study</description>
          </group>
          <group group_id="O2">
            <title>Unilateral TENS (Uni-TENS) Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side and sham electrical stimulation on the non-paretic side&#xD;
Task-orientated training: Task-Oriented Training (TOT) is a goal-directed exercise therapy, which help the people derive optimal control strategies for solving specific motor problems in real environment. In this study, TOT included stretching exercises, mobilizing exercise, strengthening exercises, seated reaching tasks, dexterity training and bimanual practice.&#xD;
Transcutaneous electrical nerve stimulation (TENS): The stimulator was 120z Dual-Channel TENS Unit (ITO PHYSITHERAPY&amp;REHABILITION CO., LTD, Tokyo, Japan). The parameter (100 Hz, 0.2 ms square pulses, intensity barely below the motor threshold) of TENS followed our previous study&#xD;
Sham electrical nerve stimulation: A identical-looking TENS devices that electrical circuit has been disconnected.</description>
          </group>
          <group group_id="O3">
            <title>Placebo Group</title>
            <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation&#xD;
Task-orientated training: Task-Oriented Training (TOT) is a goal-directed exercise therapy, which help the people derive optimal control strategies for solving specific motor problems in real environment. In this study, TOT included stretching exercises, mobilizing exercise, strengthening exercises, seated reaching tasks, dexterity training and bimanual practice.&#xD;
Sham electrical nerve stimulation: A identical-looking TENS devices that electrical circuit has been disconnected.</description>
          </group>
          <group group_id="O4">
            <title>Control Group</title>
            <description>No Active intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Maximal Voluntary Contraction (MVC)-Cocontraction Ratio</title>
          <description>EMG signal of Radial Carpi Extensor and Ulnar Carpi Flexor for both affected and unaffected side would be recorded by the surface EMG electrodes when asked the subjects to perform the MVC of wrist extension and flexion for 5s in each trial. Each movement would perform 3 times. The data of the 3 trials will be averaged. The co-contraction ratio would be calculated by the iEMG area of antagonist to total (agonist+antagonist), which would be captured for 0.5s from the window began at 0.25s before and ended at 0.25s after the peak value of MVC.</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Co-contraction Ratio of Wrist Flexion-pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="0.14"/>
                    <measurement group_id="O2" value="0.24" spread="0.11"/>
                    <measurement group_id="O3" value="0.25" spread="0.15"/>
                    <measurement group_id="O4" value="0.24" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Co-contraction Ratio of Wrist Flexion-mid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" spread="0.13"/>
                    <measurement group_id="O2" value="0.27" spread="0.13"/>
                    <measurement group_id="O3" value="0.23" spread="0.11"/>
                    <measurement group_id="O4" value="0.24" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Co-contraction Ratio of Wrist Flexion-post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" spread="0.14"/>
                    <measurement group_id="O2" value="0.28" spread="0.12"/>
                    <measurement group_id="O3" value="0.25" spread="0.12"/>
                    <measurement group_id="O4" value="0.24" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Co-contraction Ratio of Wrist Flexion-follow up 1 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" spread="0.16"/>
                    <measurement group_id="O2" value="0.26" spread="0.11"/>
                    <measurement group_id="O3" value="0.25" spread="0.10"/>
                    <measurement group_id="O4" value="0.25" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Co-contraction Ratio of Wrist Flexion-follow up 3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.16"/>
                    <measurement group_id="O2" value="0.25" spread="0.11"/>
                    <measurement group_id="O3" value="0.23" spread="0.15"/>
                    <measurement group_id="O4" value="0.23" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Co-contraction Ratio of Wrist Extension-pre</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.16"/>
                    <measurement group_id="O2" value="0.31" spread="0.23"/>
                    <measurement group_id="O3" value="0.25" spread="0.15"/>
                    <measurement group_id="O4" value="0.23" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Co-contraction Ratio of Wrist Extension-mid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="0.12"/>
                    <measurement group_id="O2" value="0.28" spread="0.20"/>
                    <measurement group_id="O3" value="0.26" spread="0.15"/>
                    <measurement group_id="O4" value="0.22" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Co-contraction Ratio of Wrist Extension-post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.14"/>
                    <measurement group_id="O2" value="0.28" spread="0.21"/>
                    <measurement group_id="O3" value="0.28" spread="0.16"/>
                    <measurement group_id="O4" value="0.27" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Co-contraction Ratio of Wrist Extension-follow up 1 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.17"/>
                    <measurement group_id="O2" value="0.28" spread="0.23"/>
                    <measurement group_id="O3" value="0.26" spread="0.14"/>
                    <measurement group_id="O4" value="0.23" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Co-contraction Ratio of Wrist Extension-follow up 3 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="0.18"/>
                    <measurement group_id="O2" value="0.27" spread="0.18"/>
                    <measurement group_id="O3" value="0.27" spread="0.15"/>
                    <measurement group_id="O4" value="0.22" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>5 months (from the baseline to the follow up 3 months assessment)</time_frame>
      <desc>Baseline: There was no adverse event occurred in baseline, Mid-Intervention, Post-intervention, follow-up 1 month and follow-up 3 month.</desc>
      <group_list>
        <group group_id="E1">
          <title>Bilateral TENS (Bi-TENS) Group</title>
          <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral electrical stimulation</description>
        </group>
        <group group_id="E2">
          <title>Unilateral TENS (Uni-TENS) Group</title>
          <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with unilateral electrical stimulation on paretic side</description>
        </group>
        <group group_id="E3">
          <title>Placebo Group</title>
          <description>All subjects will undergo 20 sessions of their assigned intervention (60 minutes, thrice a week, for 8 weeks). All subjects will receive 60 minutes task-oriented upper limb training (TOT) with bilateral sham electrical stimulation</description>
        </group>
        <group group_id="E4">
          <title>Control Group</title>
          <description>No Active intervention</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The time window of the assessment may not be widen enough to observe the change in all the outcomes.&#xD;
The sample size may not be large enough provide sufficient power to detect the improvement in all the outcomes.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Prof. Shamay Ng</name_or_title>
      <organization>Department of Rehabilitation Science, The Hong Kong Polytechnic University</organization>
      <phone>27664889</phone>
      <email>shamay.ng@polyu.edu.hk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

